A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis

A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis

Bibliographic Details
Main Authors: Singh, Rishi P, Srivastava, Sunil, Ehlers, Justis P, Bedi, Rumneek, Schachat, Andrew P, Kaiser, Peter K
Format: Online
Language:English
Published: BMJ Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033174/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033174/

Similar Items